X linked News and Research

RSS

NIH awards nearly $14M grants to research on how genetic factors influence susceptibility to disease

Five research teams have received new four-year awards to study the genomics of disease susceptibility in ethnically diverse populations. The projects aim to unravel the subtle variations in genetic makeup among groups - including African-Americans, Asian-Americans, Hispanics and more - that may account for differences in risks for conditions such as high blood pressure and high blood lipids, in addition to common diseases such as cancer and heart disease.

7 Sep 2013

BMP linked to increased risk of benign tumors, not cancers

Patients undergoing spinal fusion surgery with bone morphogenetic protein (BMP) appear to be at increased risk of benign tumors—but not cancers, reports a study in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

7 Sep 2013

Researchers take detailed images of morphing structure of Parkinson’s protein

Researchers have taken detailed images and measurements of the morphing structure of a brain protein thought to play a role in Parkinson's disease, information that could aid the development of medications to treat the condition.

7 Sep 2013

NIH Funds Minority Disease Susceptibility Studies

...

6 Sep 2013

Exercise may not be ‘one size fits all’ in bipolar patients

Researchers say that more study is needed of the relationship between exercise and symptoms among patients with bipolar disorder.

6 Sep 2013

TSRI scientists identify involvement of angiomotin protein in cancer

A team led by scientists from The Scripps Research Institute have shown that a protein once thought to inhibit the growth of tumors is instead required for initial tumor growth.

6 Sep 2013

State highlights: Texas abortion clinics prepare to shutter; wide disparity in hospital prices; Calif. bill to expand abortion providers passes

A selection of health policy news from Texas, California, North Carolina, Missouri, Oregon and Colorado.

6 Sep 2013

Apoptosis can reactivate latent herpesviruses in dying cell

Researchers have found that apoptosis, a natural process of programmed cell death, can reactivate latent herpesviruses in the dying cell. The results of their research, which could have broad clinical significance since many cancer chemotherapies cause apoptosis, was published ahead of print in the Journal of Virology.

6 Sep 2013

Self-propagating aggregates key to Alzheimer's, other diseases

Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.

6 Sep 2013

Inner-ear dysfunction can increase hyperactivity, say researchers

Behavioral abnormalities are traditionally thought to originate in the brain. But a new study by researchers at Albert Einstein College of Medicine of Yeshiva University has found that inner-ear dysfunction can directly cause neurological changes that increase hyperactivity.

6 Sep 2013

Pregnant women who smoke as well as having asthma are increasing risk of complications

New research from the University of Adelaide has shown for the first time that pregnant women who smoke as well as having asthma are greatly increasing the risk of complications for themselves and their unborn children.

6 Sep 2013

Acute manic episodes linked to increased edema risk

Bipolar disorder patients admitted to hospital with a manic episode are at an increased risk for lower limb edema, compared with their peers with depressive or non-affective psychosis episodes, study findings show.

5 Sep 2013

Disease Twofer: Parkin Problem Leads To Parkinson’S And Impairs Response To TB

University of California, San Francisco researchers report that a key protein associated with Parkinson's disease also plays a major role in the destruction of the bacteria that cause tuberculosis.

5 Sep 2013

Peru: Liver cancer affects young people and children who do not have related risk factors

Liver cancer is the sixth most common cancer worldwide and the third most deadly. It mainly affects men over the age of 40, most often with cirrhosis or hepatitis B or C. But in Peru, it also uncharacteristically affects young people, even children, who do not have the identified related risk factors.

5 Sep 2013

Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

A stressful pregnancy might be the last thing a future mother needs, but it is to her unborn baby that this stress spells real trouble. All because stress hormones (called glucocorticoids or GCs) can disturb normal foetal brain development, leading to behavioural and/or emotional problems later in life.

5 Sep 2013

Journals highlight issues related to hostile sexism and society's role in creative genius

Men who generally believe that women who challenge men's power are manipulative and subversive - so-called hostile sexism - carry over those antagonistic attitudes into their intimate relationships.

5 Sep 2013

Worsening air pollution could increase annual premature deaths in 21st century

This century, climate change is expected to induce changes in air pollution, exposure to which could increase annual premature deaths by more than 100,000 adults worldwide.

5 Sep 2013

Study links herbal supplement use prior to surgery with postoperative complications

Patients electing cosmetic facial procedures such as rhinoplasty at St. Louis Cosmetic Surgery may be less likely to suffer complications, thanks to the way doctors at the practice have responded to a new study.

5 Sep 2013

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

A team led by scientists from The Scripps Research Institute (TSRI) have shown that a protein once thought to inhibit the growth of tumors is instead required for initial tumor growth. The findings could point to a new approach to cancer treatment.

5 Sep 2013

Scientists develop new form of aspirin to cope with resistance

Scientists are reporting development of a new form of aspirin - taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke - that could extend aspirin's benefits to people who may not respond to the drug. Their advance toward coping with "aspirin resistance" appears in the journal ACS Nano.

5 Sep 2013

X linked News and Research

NIH awards nearly $14M grants to research on how genetic factors influence susceptibility to disease

BMP linked to increased risk of benign tumors, not cancers

Researchers take detailed images of morphing structure of Parkinson’s protein

NIH Funds Minority Disease Susceptibility Studies

Exercise may not be ‘one size fits all’ in bipolar patients

TSRI scientists identify involvement of angiomotin protein in cancer

State highlights: Texas abortion clinics prepare to shutter; wide disparity in hospital prices; Calif. bill to expand abortion providers passes

Apoptosis can reactivate latent herpesviruses in dying cell

Self-propagating aggregates key to Alzheimer's, other diseases

Inner-ear dysfunction can increase hyperactivity, say researchers

Pregnant women who smoke as well as having asthma are increasing risk of complications

Acute manic episodes linked to increased edema risk

Disease Twofer: Parkin Problem Leads To Parkinson’S And Impairs Response To TB

Peru: Liver cancer affects young people and children who do not have related risk factors

Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

Journals highlight issues related to hostile sexism and society's role in creative genius

Worsening air pollution could increase annual premature deaths in 21st century

Study links herbal supplement use prior to surgery with postoperative complications

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

Scientists develop new form of aspirin to cope with resistance

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News